Strategic patent benchmark actions against Tuberculosis

Tuberculosis (TB) is the second cause of death lead by infectious disease worldwide and with a growing incidence and death rates by 2022. United Nations preventive and treatment targets to fight TB were unmet and the upcoming TB patent portfolio is vulnerable what jeopardize global progress against TB. Funding for TB research is limited and strategical initiatives through intellectual property could be applied to optimize public and private efforts to fight TB epidemic. To stimulate the research and drug market aspects related with TB technologies, it was synthetized through searches in technological databases 15 strategic actions to enhance development and access of TB assets at regional, national and international level.